SEC Form 4 · accession 0001190725-15-000094
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dave Helsel
Officer — EVP, Global Manufacturing
Period of report
Apr 13, 2015
Accepted (ET)
Apr 14, 2015 · 1:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 13, 2015 | D | 302 | $43.7281 | D | 13,216 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to a 10b5-1 Plan to cover tax liability for released shares.